Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia.

Front Oncol · 2021 · PMC8415411 · PMID 34485147

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

In conclusion, although the current data do not provide definitive evidence supporting the effects of low-dose decitabine maintenance treatment on the prevention of relapse after ALL transplantation, the overall results are encouraging and still indicate a positive trend.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.